Results 21 to 30 of about 984,572 (204)

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis [PDF]

, 2010
Background: FibroTest (FT) is the most frequently used serum fibrosis marker and consists of an algorithm of five fibrosis markers (alfa2-macroglobulin, apolipoproteinA1, haptoglobin, GGT, bilirubin). The Enhanced Liver Fibrosis (ELF) test consists of an
Julie Parkes, Stefan Zeuzem, Herrmann, Eva, Friedrich-Rust, Mireen, William Rosenberg, Sarrazin, Christopher, Mireen Friedrich-Rust, Sarrazin, Christoph, Christoph Sarrazin, Parkes, Julie, Eva Herrmann, Rosenberg, William, Zeuzem, Stefan   +12 more
core   +2 more sources

Changes in Etiologies of Hospitalized Patients with Liver Cirrhosis in Beijing 302 Hospital from 2002 to 2013

Mediators of Inflammation, 2017
Background. Over the last 20 years, the prevalence of hepatitis B virus (HBV) infection in China has decreased gradually due to the application of a national HBV vaccination program.
Binxia Chang, Baosen Li, Ying Sun, Guangju Teng, Ang Huang, Jin Li, Zhengsheng Zou   +6 more
doaj   +1 more source

Features of the State of Internal Organs and the Structure of Comorbidity in Deceased Persons With Alcoholic Liver Cirrhosis, Non-alcoholic Fatty Liver Disease at the Cirrhosis Stage and Alcoholic Liver Cirrhosis Associated With Insulin Resistance and Obesity

, 2020
Introduction. Today, the most common pathologies among the chronic diffuse liver diseases is non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease. The aim of the study. The aim of the work was to study the peculiarities of the the state
N. Matkovska
core   +1 more source

Drug-related problems and dosage adjustment in patients with liver disease [PDF]

, 2012
The liver is essential for the metabolism of medicinal substances. Liver disease, especially liver cirrhosis, may lead to various pharmacokinetic and pharmacodynamic changes, predisposing patients with liver cirrhosis to adverse drug events (ADEs).
Franz, Carmen Carina
core   +1 more source

Cystic fibrosis related chronic liver disease: a study of its influence upon prognosis and possible mechanisms for this; with specific reference to pulmonary and systemic haemodynamics [PDF]

, 1995
MDTo assess the influence of chronic liver disease on survival a time dependent multivariate Cox regression analysis was It performed. The results confirmed that patients with evidence of chronic liver disease have a worse prognosis.
Williams, Simon Graham John
core   +4 more sources

To Study the Activity of Paraoxonase-1 and High Density Lipoprotein-Cholesterol in Alcoholic Liver Cirrhosis [PDF]

Journal of Krishna Institute of Medical Sciences University, 2017
Background: Alcoholic liver cirrhosis is the most common complication of ethanol abuse. Alcoholic fatty liver progresses to alcoholic hepatitis, cirrhosis and liver failure.
Pooja Nemagoudar, Padmaja Nikam, Shashikant Nikam, Naren Nimbal   +3 more
doaj  

Alcoholic liver disease: A current molecular and clinical perspective

Liver Research, 2018
Heavy alcohol use is the cause of alcoholic liver disease (ALD). The ALD spectrum ranges from alcoholic steatosis to steatohepatitis, fibrosis, and cirrhosis.
Koichiro Ohashi, Michael Pimienta, Ekihiro Seki   +2 more
doaj   +1 more source

Comparative Study of 5’- Nucleotidase Test in Various Liver Diseases [PDF]

Journal of Clinical and Diagnostic Research, 2016
Introduction: The liver regulates many important metabolic functions. The 5’-nucleotidase activity is increased in obstructive jaundice, parenchymal liver disease, and hepatic metastases. Aim: This study was conducted to assess the serum levels of 5’-
Mohd Azam Hyder, Marghoob Hasan, Abdelmarouf Mohieldein   +2 more
doaj   +1 more source

Anticoagulation for Atrial Fibrillation in Patients with Decompensated Liver Cirrhosis: Bold and Brave?

Diagnostics, 2023
Atrial fibrillation is frequently diagnosed in patients with liver cirrhosis, especially in those with non-alcoholic steatohepatitis or alcoholic etiology.
Irina Gîrleanu, Anca Trifan, Laura Huiban, Cristina Maria Muzica, Oana Cristina Petrea, Ana-Maria Sîngeap, Camelia Cojocariu, Stefan Chiriac, Tudor Cuciureanu, Remus Stafie, Sebastian Zenovia, Ermina Stratina, Adrian Rotaru, Robert Nastasa, Catalin Sfarti, Irina Iuliana Costache, Carol Stanciu   +16 more
doaj   +1 more source

Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis [PDF]

Cochrane Database of Systematic Reviews, 2000
Abstract: Aims/Background: Colchicine is an anti‐inflammatory and anti‐fibrotic drug. Several randomized clinical trials have addressed the question whether colchicine has any efficacy in patients with alcoholic as well as non‐alcoholic fibrosis and cirrhosis.
A, Rambaldi, C, Gluud
openaire   +5 more sources